Search clinical trials for: Dimethyl fumarate

Total 1894 results

AstraZeneca

Completed

Atlantis Symbicort

Asthma
AstraZeneca

Completed

Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

Chronic Obstructive Pulmonary Disease

China
AstraZeneca

Completed

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients

Chronic Obstructive Pulmonary Disease

United States, Czech Republic, Poland, South Africa, Netherlands
AstraZeneca

Completed

Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic

Schizophrenia

China
AstraZeneca

Completed

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Bipolar I Disorder

United States, Sweden, Bulgaria, France, Italy, Poland, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Czech Republic, Hungary, Finland, Norway, Australia, Belgium
AstraZeneca

Completed

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders (OPAL)

Major Depressive Disorder

United States
AstraZeneca

Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder (MOONSTONE)

Major Depressive Disorder

United States
AstraZeneca

Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder (DIAMOND)

Major Depressive Disorder

United States
AstraZeneca

Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder (GOLD)

Generalized Anxiety Disorder

United States
AstraZeneca

Completed

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

Mania | Manic Disorder | Manic State | Affective Psychosis, Bipolar | Manic-Depressive Psychosis | Psychoses, Manic-Depressive

United States
AstraZeneca

Completed

Fast Titration in the Treatment of Schizophrenia, Taiwan

Schizophrenia

Taiwan
AstraZeneca

Completed

Seroquel- Agitation Associated With Dementia

Vascular Dementia | Alzheimer's Disease
AstraZeneca

Completed

Phase III/Seroquel SR Bipolar Depression Monotherapy - US

Depression, Bipolar | Affective Psychosis, Bipolar | Manic-Depressive Psychosis | Psychoses, Manic-Depressive

United States
AstraZeneca

Completed

Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients. (PLATINUM)

Anxiety Disorders

United States, Korea, Republic of, Russian Federation, United Kingdom, Germany, Philippines, Hungary, Finland, Canada, Australia, Indonesia
AstraZeneca

Completed

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders (PEARL)

Major Depressive Disorder

United States
AstraZeneca

Completed

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Schizophrenia

United States
AstraZeneca

Completed

Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects

Schizophrenia | Schizoaffective Disorders

Canada
AstraZeneca

Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder (TITANIUM)

Generalized Anxiety Disorder

United States
AstraZeneca

Completed

Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder (UNIQUE)

Major Depressive Disorder

Belgium
AstraZeneca

Completed

Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder (AMETHYST)

Major Depressive Disorder

United States, Russian Federation, United Kingdom, Romania, Canada, Slovakia, Bulgaria, Puerto Rico
AstraZeneca

Completed

Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia (SCORE)

Schizophrenia

Sweden
Allergy and Asthma Center of El Paso
GlaxoSmithKline

Unknown

Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)

Asthma

United States
Cancer Research UK
Cancer Society Auckland

Completed

Study of DMXAA (Now Known as ASA404) in Solid Tumors (DMXAA)

Solid Tumors
AstraZeneca

Completed

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy (RELEASE)

Asthma

United Kingdom
AstraZeneca

Completed

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

Asthma

Germany
Lindner Center of HOPE
AstraZeneca; University of Cincinnati

Completed

Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms

Bipolar Disorder

United States
Dey

Completed

A Crossover Study in the Treatment of Patients With COPD

Chronic Obstructive Pulmonary Disease

United States
National Institutes of Health (NIH)

Completed

Cereals as a Source of Iron for Breastfed Infants (Bfe03B)

Iron Deficiency

United States
Guangzhou Mental Hospital
First Affiliated Hospital of Jinan University; Second Affiliated Hospital of... and other collaborators

Unknown

A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder

Bipolar Disorder

China
Synvista Therapeutics, Inc

Terminated

Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

Psoriasis

Israel
Campus Bio-Medico University
University of Padova; University of Genova

Completed

Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis

Vernal Keratoconjunctivitis

Italy
US Department of Veterans Affairs

Completed

Antipsychotic Response in Schizophrenia

Schizophrenia

United States
US Department of Veterans Affairs

Completed

Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
AstraZeneca

Completed

Quetiapine Fumarate Bipolar Maintenance Monotherapy (SPaRCLe)

Bipolar Disorder

United States, Bulgaria, Peru, Russian Federation, Philippines, Malaysia, Lithuania, Romania, Ukraine, Argentina, Taiwan, Mexico, Thailand, India, Colombia
AstraZeneca

Completed

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder (SILVER)

Generalized Anxiety Disorder

Sweden, Bulgaria, Czech Republic, France, Mexico, South Africa, Spain, Germany, Romania, Finland, Norway, Argentina, Canada, Denmark, Slovakia
AstraZeneca

Completed

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder (AMBER)

Major Depressive Disorder

Korea, Republic of, Mexico, South Africa, China, Finland, Canada, Spain, Philippines, Malaysia
AstraZeneca

Completed

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Bipolar Disorder

United States, Canada
Creighton University
AstraZeneca

Completed

Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety

Alcoholism | Obsessive-Compulsive Disorder | Anxiety Disorders | Generalized Anxiety Disorder | Panic Disorder | Post-Traumatic Stress Disorder

United States
Inje University

Terminated

Quality of Life (QOL) in Female Patient With Schizophrenia

Schizophrenia

Korea, Republic of
Hannover Medical School
Pharmacia

Completed

L-Arginine and Erectile Dysfunction

Erectile Dysfunction

Germany
Laval University
AstraZeneca

Completed

Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic Subjects (D5890L00013)

Asthma

Canada
NHS Greater Glasgow and Clyde

Terminated

Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease

Heart Failure | Chronic Obstructive Pulmonary Disease

United Kingdom
Shanghai Jiao Tong University School of Medicine

Unknown

To Evaluate the Efficiency and Safety of Quetiapine Fumarate in the Treatment of Acute Manic Patients With Bipolar Disorder.

Bipolar Disorder

China
Hospital General de Requena
Esteve

Completed

Efficacy of Budesonide-Formoterol in Bronchiectasis

Bronchiectasis

Spain
Medical University of Vienna

Completed

Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions

Ocular Physiology | Regional Blood Flow

Austria
University of Medicine and Dentistry of New Jersey
AstraZeneca

Completed

Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder

Borderline Personality Disorder

United States
Gilead Sciences

Completed

SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada

HIV-1 Infection

Germany
Mood Disorders Center of Ottawa
AstraZeneca

Completed

Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders

Bipolar Disorder

Canada
Solvay Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/S

Terminated

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Schizophrenia

United States, Argentina, Canada, Chile, Czech Republic, Estonia, Finland, Germany, Hungary, Latvia, Lithuania, Peru, Slovakia, South Africa
Orlando Immunology Center
GlaxoSmithKline

Completed

Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

HIV Infections

United States

Search clinical trials for: Dimethyl fumarate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations